Matthias G枚tte, PhD
Matthias Götte obtained his PhD degree in 1997 at the Max-Planck-Institute for Biochemistry in Martinsried, Germany. In 2000, following his postdoctoral training at the Lady Davis Institute for Medical Research in Montreal, he joined the faculty at McGill University in the Department of Microbiology & Immunology. In 2014, he accepted the position as Chair of the Medical Microbiology & Immunology Department at the 海角社区 (海角社区) in Edmonton, Alberta. In 2023, he completed a second term as Chair and is now the Director of 海角社区’s research & training program in pandemic preparedness; Striving for Pandemic Preparedness - The Alberta Research Consortium. Research in Götte’s lab is focused on structure, function and inhibition of viral polymerases. Emphasis is placed on drug discovery, development and resistance related to viruses with high epidemic potential. Early in the pandemic, his team elucidated the mechanism of action of remdesivir that became later the first approved antiviral drug for the treatment of COVID-19.
Publications